Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iran Darouk Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer specializing in the development and production of herbal and natural medicines. Founded in 1981, the company operates extensive manufacturing facilities in Tehran that are GMP-certified for the production of various dosage forms, including tablets, drops, syrups, and ointments. Their product portfolio is diverse, covering therapeutic areas such as gastroenterology, respiratory health, and neurology, with well-known brands like Senalin and Altadin. Iran Darouk focuses on bridging traditional herbal knowledge with modern scientific validation and pharmaceutical technology. The company is a subsidiary of the Alborz Investment Group and is publicly traded on the Tehran Stock Exchange. It plays a significant role in the Iranian healthcare sector by providing affordable, plant-based alternatives to synthetic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iran Darouk Pharmaceutical Company.